Publication | Closed Access

A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension

HypertensionCardiovascular DiseaseAntihypertensive AgentsAntihypertensive TherapyPharmacologyCardiovascular PharmacologyFull Dose RangeMild-to-moderate HypertensionPharmacotherapyMedicineDouble-blind ComparisonBlood Pressure